Advertisement

Topics

COUNTERPOINT: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer

10:30 EDT 15 May 2018 | Cancer Networks

Abiraterone has become the first-choice treatment for men with metastatic prostate cancer.

Original Article: COUNTERPOINT: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer

NEXT ARTICLE

More From BioPortfolio on "COUNTERPOINT: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer"

Advertisement
Quick Search
Advertisement
Advertisement